This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Woodward, T. L. Articles by Haslam, S. Z. Search for Related Content PubMed PubMed Citation Articles by Woodward, T. L. Articles by Haslam, S. Z.

Laminin Inhibits Estrogen Action in Human Breast Cancer Cells¹

Department of Physiology, Michigan State University, East Lansing, Michigan 48824-1101

Address all correspondence and requests for reprints to: Sandra Z. Haslam, Michigan State University, Department of Physiology, 108 Giltner Hall, East Lansing, Michigan 48824-1101. E-mail: shaslam{at}pilot.msu.edu

Breast tumors that lack estrogen responsiveness have a poor prognosis. Despite the critical importance to breast cancer treatment, little is known about the loss of estrogen responsiveness and the development of antiestrogen resistance. We have examined the regulation of estrogen-induced proliferation, estrogen regulation of progesterone receptor (PR) expression, and estrogen signaling pathways in estrogen receptor (ER) positive (MCF-7 and T47D) breast cancer cell lines by specific extracellular matrix proteins (ECM) under serum-free conditions. Estrogen, supplemented with submaximal concentrations of insulin-like growth factor I (IGF-I) and epidermal growth factor (EGF), stimulated DNA synthesis of MCF-7 cells 7- to 10-fold and T47D cells 2-fold on collagen I or fibronectin. However, estrogen-induced proliferation was greatly reduced on laminin. In contrast, IGF-I or EGF, alone, stimulated proliferation of MCF-7 and T47D cells on all ECM. Thus, ER+ breast cancer cells were not refractory to mitogens when cultured on laminin. Similarly, estrogen induction of PR occurred on fibronectin or collagen I, but not on laminin. While ER content was similar on all ECM, estrogen stimulation of estrogen response element (ERE)-luciferase activity was significantly lower in MCF-7 cells cultured on laminin. Therefore, changes in ECM composition that occur in breast cancer may alter estrogen-responsiveness and the effectiveness of antiestrogen therapies in ER+ breast cancer cells.

This article has been cited by other articles:

				K.-M. Ng, M. G. Catalano, T. Pinos, D. M. Selva, G. V. Avvakumov, F. Munell, and G. L. Hammond Evidence That Fibulin Family Members Contribute to the Steroid-dependent Extravascular Sequestration of Sex Hormone-binding Globulin J. Biol. Chem., June 9, 2006; 281(23): 15853 - 15861. [Abstract] [Full Text] [PDF]

				A. A.A. Ewies, J. Thompson, and F. Al-Azzawi Changes in gonadal steroid receptors in the cardinal ligaments of prolapsed uteri: immunohistomorphometric data Hum. Reprod., July 1, 2004; 19(7): 1622 - 1628. [Abstract] [Full Text] [PDF]

				S. D. K. Berry, R. D. Howard, and R. M. Akers Mammary Localization and Abundance of Laminin, Fibronectin, and Collagen IV Proteins in Prepubertal Heifers J Dairy Sci, September 1, 2003; 86(9): 2864 - 2874. [Abstract] [Full Text] [PDF]

				V. Novaro, C. D. Roskelley, and M. J. Bissell Collagen-IV and laminin-1 regulate estrogen receptor {alpha} expression and function in mouse mammary epithelial cells J. Cell Sci., July 15, 2003; 116(14): 2975 - 2986. [Abstract] [Full Text] [PDF]

				H. Varma and S. E. Conrad Antiestrogen ICI 182,780 Decreases Proliferation of Insulin-like Growth Factor I (IGF-I)-treated MCF-7 Cells without Inhibiting IGF-I Signaling Cancer Res., July 15, 2002; 62(14): 3985 - 3991. [Abstract] [Full Text] [PDF]

				T. L. Woodward, A. S. Mienaltowski, R. R. Modi, J. M. Bennett, and S. Z. Haslam Fibronectin and the {{alpha}}5{beta}1 Integrin Are Under Developmental and Ovarian Steroid Regulation in the Normal Mouse Mammary Gland Endocrinology, July 1, 2001; 142(7): 3214 - 3222. [Abstract] [Full Text] [PDF]